183 related articles for article (PubMed ID: 23129362)
1. Peroxisome proliferator-activated receptor-γ cofactors in neurodegeneration.
Katsouri L; Blondrath K; Sastre M
IUBMB Life; 2012 Dec; 64(12):958-64. PubMed ID: 23129362
[TBL] [Abstract][Full Text] [Related]
2. PGC-1alpha, a new therapeutic target in Huntington's disease?
McGill JK; Beal MF
Cell; 2006 Nov; 127(3):465-8. PubMed ID: 17081970
[TBL] [Abstract][Full Text] [Related]
3. Positive correlation between PPARgamma/PGC-1alpha and gamma-GCS in lungs of rats and patients with chronic obstructive pulmonary disease.
Li J; Dai A; Hu R; Zhu L; Tan S
Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):603-14. PubMed ID: 20732852
[TBL] [Abstract][Full Text] [Related]
4. PPAR(gamma)/PGC-1(alpha) pathway in E-cadherin expression and motility of HepG2 cells.
Lee HJ; Su Y; Yin PH; Lee HC; Chi CW
Anticancer Res; 2009 Dec; 29(12):5057-63. PubMed ID: 20044617
[TBL] [Abstract][Full Text] [Related]
5. The dysfunction of hepatic transcriptional factors in mice with Huntington's Disease.
Chiang MC; Chern Y; Juo CG
Biochim Biophys Acta; 2011 Sep; 1812(9):1111-20. PubMed ID: 21651979
[TBL] [Abstract][Full Text] [Related]
6. Structural and biochemical basis for the binding selectivity of peroxisome proliferator-activated receptor gamma to PGC-1alpha.
Li Y; Kovach A; Suino-Powell K; Martynowski D; Xu HE
J Biol Chem; 2008 Jul; 283(27):19132-9. PubMed ID: 18469005
[TBL] [Abstract][Full Text] [Related]
7. PPARγ and PGC-1α as therapeutic targets in Parkinson's.
Corona JC; Duchen MR
Neurochem Res; 2015 Feb; 40(2):308-16. PubMed ID: 25007880
[TBL] [Abstract][Full Text] [Related]
8. The orphan nuclear receptor DAX-1 acts as a novel transcriptional corepressor of PPARgamma.
Kim GS; Lee GY; Nedumaran B; Park YY; Kim KT; Park SC; Lee YC; Kim JB; Choi HS
Biochem Biophys Res Commun; 2008 May; 370(2):264-8. PubMed ID: 18381063
[TBL] [Abstract][Full Text] [Related]
9. Modulation of energy deficiency in Huntington's disease via activation of the peroxisome proliferator-activated receptor gamma.
Chiang MC; Chen CM; Lee MR; Chen HW; Chen HM; Wu YS; Hung CH; Kang JJ; Chang CP; Chang C; Wu YR; Tsai YS; Chern Y
Hum Mol Genet; 2010 Oct; 19(20):4043-58. PubMed ID: 20668093
[TBL] [Abstract][Full Text] [Related]
10. The role of PGC-1α in the pathogenesis of neurodegenerative disorders.
Róna-Vörös K; Weydt P
Curr Drug Targets; 2010 Oct; 11(10):1262-9. PubMed ID: 20840068
[TBL] [Abstract][Full Text] [Related]
11. Huntington's disease--making connections.
Greenamyre JT
N Engl J Med; 2007 Feb; 356(5):518-20. PubMed ID: 17267914
[No Abstract] [Full Text] [Related]
12. Curcumin regulates peroxisome proliferator-activated receptor-γ coactivator-1α expression by AMPK pathway in hepatic stellate cells in vitro.
Zhai X; Qiao H; Guan W; Li Z; Cheng Y; Jia X; Zhou Y
Eur J Pharmacol; 2015 Jan; 746():56-62. PubMed ID: 25445048
[TBL] [Abstract][Full Text] [Related]
13. Roles of transcriptional corepressor RIP140 and coactivator PGC-1α in energy state of chronically infarcted rat hearts and mitochondrial function of cardiomyocytes.
Chen Y; Wang Y; Chen J; Chen X; Cao W; Chen S; Xu S; Huang H; Liu P
Mol Cell Endocrinol; 2012 Oct; 362(1-2):11-8. PubMed ID: 22503866
[TBL] [Abstract][Full Text] [Related]
14. PGC-1α sparks the fire of neuroprotection against neurodegenerative disorders.
Lv J; Jiang S; Yang Z; Hu W; Wang Z; Li T; Yang Y
Ageing Res Rev; 2018 Jul; 44():8-21. PubMed ID: 29580918
[TBL] [Abstract][Full Text] [Related]
15. Scavenger receptor CD36 mediates inhibition of cholesterol synthesis via activation of the PPARγ/PGC-1α pathway and Insig1/2 expression in hepatocytes.
Rodrigue-Way A; Caron V; Bilodeau S; Keil S; Hassan M; Lévy E; Mitchell GA; Tremblay A
FASEB J; 2014 Apr; 28(4):1910-23. PubMed ID: 24371122
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator activated receptor-alpha (PPARα) and PPAR gamma coactivator-1alpha (PGC-1α) regulation of cardiac metabolism in diabetes.
Duncan JG
Pediatr Cardiol; 2011 Mar; 32(3):323-8. PubMed ID: 21286700
[TBL] [Abstract][Full Text] [Related]
17. Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration.
Weydt P; Pineda VV; Torrence AE; Libby RT; Satterfield TF; Lazarowski ER; Gilbert ML; Morton GJ; Bammler TK; Strand AD; Cui L; Beyer RP; Easley CN; Smith AC; Krainc D; Luquet S; Sweet IR; Schwartz MW; La Spada AR
Cell Metab; 2006 Nov; 4(5):349-62. PubMed ID: 17055784
[TBL] [Abstract][Full Text] [Related]
18. Ligand-dependent coactivation of the human bile acid receptor FXR by the peroxisome proliferator-activated receptor gamma coactivator-1alpha.
Savkur RS; Thomas JS; Bramlett KS; Gao Y; Michael LF; Burris TP
J Pharmacol Exp Ther; 2005 Jan; 312(1):170-8. PubMed ID: 15329387
[TBL] [Abstract][Full Text] [Related]
19. PPARgamma-PGC-1alpha activity is determinant of alcohol related breast cancer.
Petersen RK; Larsen SB; Jensen DM; Christensen J; Olsen A; Loft S; Nellemann C; Overvad K; Kristiansen K; Tjønneland A; Vogel U
Cancer Lett; 2012 Feb; 315(1):59-68. PubMed ID: 22050908
[TBL] [Abstract][Full Text] [Related]
20. TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model.
Palomer X; Alvarez-Guardia D; Rodríguez-Calvo R; Coll T; Laguna JC; Davidson MM; Chan TO; Feldman AM; Vázquez-Carrera M
Cardiovasc Res; 2009 Mar; 81(4):703-12. PubMed ID: 19038972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
